Fig. 6From: Identification of a novel S6K1 inhibitor, rosmarinic acid methyl ester, for treating cisplatin-resistant cervical cancerS6K1 is activated in cisplatin-resistant cervical cancer cells. a Immunoblotting analysis of HeLa and SiHa cells treated with cisplatin (5 μM) for 24 h. b Immunoblotting analysis of HeLa and SiHa cells treated with cisplatin (0, 5, 10, 20 μM) for 24 hBack to article page